Phase 2 Readout~quarter

Phase 2 Readout: hidradenitis suppurativa (HS)

ABBV overview →Track this catalyst
Indication
hidradenitis suppurativa (HS)

Other upcoming events for ABBV

Phase 2 StartPhase 2 Start: A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects With Moderately to Severel
Phase 3 ReadoutPhase 3 Topline: A Multicenter, Double-masked, Randomized Study to Compare the Efficacy and Safety of the ABBV-444 Te
Phase 3 ReadoutPhase 3 Topline: Randomized, Double-blind, Placebo-Controlled, Multiple-Attack Study With an Open-Label Extension to
Phase 3 ReadoutPhase 3 Topline: A Phase 3 Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy an
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

  • 200 free AI credits / month to run live multi-agent analysis
  • Watchlist, catalyst alerts & the biotech event calendar
  • Full pipeline, financials & FDA data on every company
Start Free
    Phase 2 Readout: hidradenitis suppurativa (HS) — ABBV Phase 2 Readout | BioSniper